Related Experiment Videos
[Experiences with antiretroviral combination therapy].
U S Justesen1, L H Mygind, S S Pedersen
1Odense Universitetshospital, medicinsk afdeling C.
Ugeskrift for Laeger
|April 22, 1999
Summary
Triple drug antiretroviral therapy significantly reduces human immunodeficiency virus (HIV) RNA levels and increases CD4 cell counts in patients. Clinical practice results demonstrate efficacy comparable to controlled trials.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- Human immunodeficiency virus (HIV) infection remains a significant global health challenge.
- Effective antiretroviral therapy (ART) is crucial for managing HIV and preventing disease progression.
Purpose of the Study:
- To evaluate the real-world efficacy of a specific triple-drug ART regimen in HIV-infected patients.
- To assess the impact of this treatment on viral load and CD4 cell counts over one year.
Main Methods:
- A cohort of 61 HIV-infected patients received a combination of two nucleoside analogues and one protease inhibitor.
- Patients were monitored for plasma HIV RNA levels, CD4 cell counts, and adverse events for up to one year.
Main Results:
- Median plasma HIV RNA levels decreased from 20,000 to < 200 copies/ml.
- The proportion of patients with plasma HIV RNA < 200 copies/ml increased from 7.5% to 65.2%.
- CD4 cell counts rose from a median of 180 to 300 x 10(6)/l.
Conclusions:
- Triple-drug ART demonstrates significant effectiveness in reducing HIV RNA and improving CD4 cell counts in clinical practice.
- The observed outcomes in real-world settings align with results from controlled clinical trials, supporting this treatment regimen's utility.